Oncology Information Systems Market Size, Share, Opportunities, And Trends By Product (Solutions, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology), By End-User (Hospitals & Diagnostic Imaging Centers, Government Institutions, Research Facilities), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061616023
  • Pages : 150

The oncology information systems market is anticipated to reach a market size of US$5.66 billion in 2028.

The oncology information systems market is anticipated to grow at a steady pace throughout the forecast period. Oncology Information Systems (OIS) are specialized software solutions designed to support healthcare providers, particularly oncologists and oncology teams, in managing and streamlining the care of cancer patients. Rising cancer cases along with technological advancements are major growth drivers of the oncology information systems market. Moreover, the increasing focus on clinical trials and government initiatives are further stimulating the oncology information systems market growth.

Rising Cancer Prevalence

The incidence of cancer has been increasing globally, placing a higher demand on oncology services. OIS assists healthcare providers in efficiently managing the growing number of cancer patients and handling their complex treatment plans. Therefore, the rising prevalence is contemplated to augment the oncology information systems market growth. For instance, approximately 20 million cancer cases worldwide were reported in 2020 according to Cancer Research UK. Moreover, around 13.9 new cases emerge every year as per the ICMR. Additionally, the number of breast cancer cases reported in the UK every year is 56,000 and the prevalence rate has doubled in the past 50 years in England according to Breast Cancer UK.

Technological Advancements

OIS continually evolves with technological advancements such as improved imaging capabilities, treatment planning algorithms, and data analytics. These developments enhance the efficiency and accuracy of cancer diagnosis and stimulate the oncology information systems market growth. Advances in biotechnology have led to breakthroughs in genomics, personalized medicine, gene editing (e.g., CRISPR), and regenerative medicine offering new possibilities for healthcare and improving human health. For example, the two coronavirus vaccines with the highest level of efficacy are based on messenger RNA, a technique that has been in development for 20 years.

Increasing Focus on Research and Clinical Trials

OIS offers features that support oncology research, clinical trials, and outcomes analysis. As cancer research and clinical trial activity increases, OIS becomes a valuable tool for managing and analyzing the resulting data. Researchers at the Memorial Sloan Kettering Cancer Centre, the American Cancer Society, and Seattle's Fred Hutchinson Cancer Centre are working together on the Quit2Heal trial. In this study, two smartphone apps for cancer patients who want to stop smoking are compared. Moreover, a collection of precision medicine cancer clinical studies called ComboMATCH (Combination Therapy Platform study with Molecular Analysis for Therapy Choice) includes a registration study and multiple treatment clinical trials supported by NCI.

Remote and Telemedicine Capabilities and Expansion

The COVID-19 pandemic accelerated the adoption of telemedicine and remote care in healthcare. For example, a San Francisco internal care doctor claims that throughout 2020, the number of virtual visits to her practice increased, and today, around one-third of her patient encounters are still in person. OIS with telemedicine capabilities allows oncologists to provide consultations and monitor patients remotely, improving access to care and thereby boosting the oncology information systems market. Moreover, telemedicine visits witnessed a remarkable surge with a 154% rise in telemedicine consultations during the last week of March 2020 in comparison to the corresponding timeframe in 2019 according to the CDC.

Government and Institutional Support

Governments and healthcare regulatory bodies in many countries have been advocating for the adoption of electronic health records and advanced healthcare technologies, including OIS thereby propelling the oncology information systems market. For instance, in August 2022, the National Cancer Grid (NCG) founded the Koita Centre for Digital Oncology (KCDO) with the aim of advancing the adoption of digital technologies and tools to enhance cancer care throughout India. Moreover, the growing adoption of OIS is further boosting market expansion. For instance, Icon Group adopted the ARIA oncology information system (OIS) with additional multi-disciplinary features in August 2021, making it the first company in the world to implement it. 

Restraints in the Market

The oncology information systems market has experienced growth and development however some restraints or challenges can impact its expansion. For example, OIS implementation may be more challenging in resource-constrained or rural areas, where access to advanced technology, internet connectivity, and skilled personnel could be limited. Moreover, integrating OIS with other healthcare information systems, such as Electronic Health Records (EHRs), Radiology Information Systems (RIS), and Picture Archiving and Communication Systems (PACS), can be complex and time-consuming.

North America is Expected to Grow Considerably

During the forecast period, North America is projected to maintain a substantial portion of the oncology information systems market. The factors attributed to such a share are the rising cancer cases, technological advancements, increasing investments, and government support. For instance, the National Cancer Institute's budget was approved by the US Congress as part of the yearly federal budgeting process in 2022. The total amount was $6.9 billion which was an increase of $353 million from 2021. Moreover, there were around 1.9 million cancer cases in 2021 according to the American Cancer Society.

Major Market Players

  • RaySearch Laboratories is a Swedish medical technology company specializing in the development of advanced software solutions for radiation therapy, oncology, and radiology. It offers a RayStation treatment planning system which is designed to assist radiation oncologists in creating highly accurate and personalized treatment plans for cancer patients undergoing radiation therapy.
  • Elekta offers brachytherapy systems for various cancer types, delivering radiation directly to the tumor site to achieve highly localized treatment. The Mosaiq Oncology Information System facilitates seamless workflow management, patient data, and treatment documentation.
  • McKesson Corporation is an American healthcare services and information technology company headquartered in Irving, Texas. McKesson offers a variety of healthcare information technology solutions designed to enhance clinical workflows, improve patient care, and optimize healthcare operations.

Key Market Developments

  • In July 2023, RaySearch Laboratories launched the latest version of RayCare called RayCare 2023B. It is the enhanced fully integrated management of radiotherapy treatment courses from prescription to the review of treatment results in RayCare.
  • In February 2023, Nova Scotia launched a first-in-Canada technology, Oncology Transformation Project (OTP) that brings together oncology in real-time. It will improve care, reduce waiting times, and enhance results with information available in a split second.
  • In December 2021, Roche introduced NAVIFY® Oncology Hub, an innovative platform designed to offer clinicians a centralized workspace for swift access to pertinent patient information. The platform securely consolidates and arranges patient data from various sources, creating a comprehensive view of the patient's cancer care journey over time.


  • By Product
    • Solutions
    • Professional Services
  • By Application
    • Medical Oncology
    • Radiation Oncology
    • Surgical Oncology
  • By End-User
    • Hospitals & Diagnostic Imaging Centers
    • Government Institutions
    • Research Facilities
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Solutions

5.3. Professional Services


6.1. Introduction

6.2. Medical Oncology

6.3. Radiation Oncology

6.4. Surgical Oncology


7.1. Introduction

7.2. Hospitals & Diagnostic Imaging Centers

7.3. Government Institutions

7.4. Research Facilities 


8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others


9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix


10.1. Varian

10.2. RaySearch Laboratories

10.3. Seimens Healthineers

10.4. Elekta

10.5. Chiuhomed

10.6. Mckesson

10.7. IQVIA

10.8. Cerner

10.9. Philips

10.10. GE Healthcare


RaySearch Laboratories

Siemens Healthineers







GE Healthcare